Data Governance Planning PDA 12 May 2015



Similar documents
MHRA GMP Data Integrity Definitions and Guidance for Industry January 2015

MHRA GMP Data Integrity Definitions and Guidance for Industry March 2015

MHRA Data Integrity Guidance and Expectations Document

ASSESSMENT OF QUALITY RISK MANAGEMENT IMPLEMENTATION

EUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL. EudraLex The Rules Governing Medicinal Products in the European Union

This interpretation of the revised Annex

EUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL. EudraLex The Rules Governing Medicinal Products in the European Union

Services Providers. Ivan Soto

PHARMACEUTICAL QUALITY SYSTEM Q10

Computerised Systems. Seeing the Wood from the Trees

Manual 074 Electronic Records and Electronic Signatures 1. Purpose

Good Research Practice

Working Party on Control of Medicines and Inspections. Final Version of Annex 16 to the EU Guide to Good Manufacturing Practice

EMA Clinical Laboratory Guidance - Key points and Clarifications PAUL STEWART

Site visit inspection report on compliance with HTA minimum standards. London School of Hygiene & Tropical Medicine. HTA licensing number 12066

From paper to electronic data

OECD DRAFT ADVISORY DOCUMENT 16 1 THE APPLICATION OF GLP PRINCIPLES TO COMPUTERISED SYSTEMS FOREWARD

GMP Training Course Quality Control October Lesley Graham Senior Inspector (UK)

GMP Issues for Start-Ups, quality in the supply chain and role of the Qualified Person (QP)

How to implement a Quality Management System

The Paperless QMS March 2012

ICH guideline Q10 on pharmaceutical quality system

Designing a CDS Landscape that Ensures You Address the Latest Challenges of the Regulatory Bodies with Ease and Confidence

New Guidelines on Good Distribution Practice of Medicinal Products for Human Use (2013/C 68/01)

GOOD DOCUMENTATION AND QUALITY MANAGEMENT PRINCIPLES. Vimal Sachdeva Technical Officer (Inspector), WHO Prequalification of Medicines Programme

Quality in pharmacovigilance systems

Guidance for Industry. Q10 Pharmaceutical Quality System

Reflection paper for laboratories that perform the analysis or evaluation of clinical trial samples

Quality Risk Management The Pharmaceutical Experience Ann O Mahony Quality Assurance Specialist Pfizer Biotech Grange Castle

GCP Inspection of Ti Trial Master Files

GCP INSPECTORS WORKING GROUP <DRAFT> REFLECTION PAPER ON EXPECTATIONS FOR ELECTRONIC SOURCE DOCUMENTS USED IN CLINICAL TRIALS

Recent Updates on European Requirements and what QPs are expected to do

How To Inspect A Blood Bank

OMCL Network of the Council of Europe QUALITY MANAGEMENT DOCUMENT

OMCL Network of the Council of Europe QUALITY ASSURANCE DOCUMENT

ICH Q10 Pharmaceutical Quality System (PQS)

RECOMMENDATION ON THE CONTENT OF THE TRIAL MASTER FILE AND ARCHIVING

Quality Assurance. Disclosure for Lilli Møller Andersen. No relevant financial relationships exist for any issue mentioned in this presentation

What is necessary to provide good clinical data for a clinical trial?

Pharmaceutical Quality Systems: US Perspective

QUESTIONS FOR YOUR SOFTWARE VENDOR: TO ASK BEFORE YOUR AUDIT

Annex 2. WHO good manufacturing practices for pharmaceutical products: main principles 1

COMPLIANCE BY DESIGN FOR PHARMACEUTICAL QUALITY CONTROL LABORATORIES INSIGHT FROM FDA WARNING LETTERS

Job description. Job title. Process Engineer. Responsible to. Process Engineering Manager. Hours/sessions per week 37.

Managing & Validating Research Data

Harmonizing Change Control Processes Globally

The Concept of Quality in Clinical Research. Dorota Śwituła Senior Clinical Quality Assurance Advisor

Good Clinical Laboratory Practice (GCLP) An international quality system for laboratories which undertake the analysis of samples from clinical trials

TRIAL MASTER FILE- SPONSORED

GAMP 4 to GAMP 5 Summary

PROPOSED UPDATED TEXT FOR WHO GOOD MANUFACTURING PRACTICES FOR PHARMACEUTICAL PRODUCTS: MAIN PRINCIPLES (JANUARY 2013)

Guideline on good pharmacovigilance practices (GVP)

United Kingdom Science Park Association Good Practice Guide Electronic Quality Management System for SMEs

Clinical database/ecrf validation: effective processes and procedures

Auditing as a Component of a Pharmaceutical Quality System

Seminario SSFA. New Guideline on Good Pharmacovigilance Practice (GVP) Fare clic per modificare lo stile del sottotitolo dello schema

ICH Q10 - Pharmaceutical Quality System

Guidance for Industry: Quality Risk Management

IT Governance. What is it and how to audit it. 21 April 2009

Adoption by GCP Inspectors Working Group for consultation 14 June End of consultation (deadline for comments) 15 February 2012

Application Of Quality Metrics In Determining Overall State Of Quality. & The Health Of Associated PQS FDA s Current Thinking

QUALITY MANAGEMENT SYSTEM (QMS) ASSESSMENT CHECKLIST

QUALITY SYSTEM REQUIREMENTS FOR PHARMACEUTICAL INSPECTORATES

Site visit inspection report on compliance with HTA minimum standards. Belfast Cord Blood Bank. HTA licensing number

This SOP may also be used by staff from other NHS areas, or organisations, with prior agreement.

Example of a food company quality

OECD SERIES ON PRINCIPLES OF GOOD LABORATORY PRACTICE AND COMPLIANCE MONITORING NUMBER 10 GLP CONSENSUS DOCUMENT

Commercial Manufacturing - Qualification & Validation-related GMP Deficiencies and Other Lifecycle Considerations

A Guide to Archiving of Electronic Records

Pharmacovigilance System Master File (PSMF), QPPV and audits

QUALITY MANAGEMENT SYSTEM REQUIREMENTS General Requirements. Documentation Requirements. General. Quality Manual. Control of Documents

COMMISSION DIRECTIVE 2003/94/EC

Document Control Procedure

FDA Title 21 CFR Part 11:Electronic Records; Electronic Signatures; Final Rule (1997)

21 CFR Part 11 Electronic Records & Signatures

ASTRAZENECA GLOBAL POLICY QUALITY AND REGULATORY COMPLIANCE

Optimizing Quality Control / Quality Assurance Agents of a Global Sourcing / Procurement Strategy

Resources Based, Manufacturing and Consumer Goods Industries Chemicals Industry

Establish Collaborative Strategies to Better Manage a Global Vendor Network Devise a Proper Float Plan

Solvency II Data audit report guidance. March 2012

Drinking Water Quality Management Plan Review and Audit Guideline

ISO/IEC QUALITY MANUAL

Implementing an ISO 9001 Quality Management System

Best Practice In A Change Management System

EUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL. EudraLex. The Rules Governing Medicinal Products in the European Union

Best Practices In Ensuring Quality Standards When Outsourcing To Contract Manufacturers, Licensees And Consultants

Conducting a Gap Analysis on your Change Control System. Presented By Miguel Montalvo, President, Expert Validation Consulting, Inc.

How To Manage An Electronic Standard Operating Procedure

State Meat and Poultry Inspection (MPI) Program Laboratory Quality Management System Checklist

Guidance for electronic trial data capturing of clinical trials

White paper: How to implement Good Documentation Practices

Enterprise Level Change Control: A Life Science Business Imperative. Presented by: Carl Ning Solutions Delivery Manager Sparta Systems

Code of Corporate Governance

"Data Manufacturing: A Test Data Management Solution"

Testing Automated Manufacturing Processes

Operations. Group Standard. Business Operations process forms the core of all our business activities

Guideline on good pharmacovigilance practices (GVP)

INSURANCE ACT 2008 CORPORATE GOVERNANCE CODE OF PRACTICE FOR REGULATED INSURANCE ENTITIES

Clinical Trial Logistics

Transcription:

Data Governance Planning PDA 12 May 2015 1

Agenda Overview of Data Integrity Assurance of Data Data Governance The Data Governance Plan Questions 2

Overview of Data Integrity 3

Data Information derived or obtained from raw data (e.g. a reported analytical result). Data can be electronic or paper based or Hybrid However all data must be: A attributable to the person generating the data L legible and permanent C contemporaneous O original record (or true copy ) A accurate Source: MHRA GMP Data Integrity Definitions and Guidance for Industry March 2015 4

Data Integrity Patient Safety Data Integrity is the extent to which all data are complete, consistent and accurate throughout the data lifecycle. Data integrity arrangements must ensure that the accuracy, completeness, content and meaning of data is retained throughout the data lifecycle. Product Quality Source: MHRA GMP Data Integrity Definitions and Guidance for Industry March 2015 5

Assurance of Data Integrity 6

How do we assure data integrity? Application of good documentation practices when using paper based, electronic or hybrid the same rules apply.. 4.9 Any alteration made to the entry on a document should be signed and dated; the alteration should permit the reading of the original information. Where appropriate, the reason for the alteration should be recorded. 4.7 Handwritten entries should be made in a clear, legible, indelible way. 4.8 Records should be made or completed at the time each action is taken and in such a way that all significant activities concerning the manufacture of medicinal products are traceable. 7

How do we assure data integrity? Use and understanding data life cycle management Retrieval (legibility) Data creation Data retention Data processing Data reporting Data review 8

How do we assure data integrity? External environmental factors Control of external environmental factors requires consideration of: Increasingly complex supply chains Outsourcing of GxP operations Economic stressors Technological advances increased use of electronic systems 9

How do we assure data integrity? Internal environmental factors Control of internal environmental factors required consideration of: Quality Management Systems Adequate understanding and control of computerised systems and paper based recording system Senior stakeholder sponsorship of data integrity assurance activities 10

Data Governance 11

Data Governance The sum total of arrangements to ensure that data, irrespective of the format in which it is generated, is recorded, processed, retained and used to ensure a complete, consistent and accurate record throughout the data lifecycle Data governance should address data ownership throughout the lifecycle, and consider the design, operation and monitoring of processes / systems in order to comply with the principles of data integrity including control over intentional and unintentional changes to information. Source: MHRA GMP Data Integrity Definitions and Guidance for Industry March 2015 12

Data Governance The data governance system should be integral to the PQS The effort and resource assigned should be commensurate with the risk to product quality Should be balanced with other QA resource demands Note: Data is not homogeneous; therefore, neither is risk this should be considered when assigning resource The expectation is not to implement a forensic approach to data checking on a routine basis, but to design and operate a system which provides an acceptable state of control based risk At its best, data governance identifies risk both business and compliance risk by increasing oversight 13

Why Enterprises Struggle With Data Governance This has been attributed to: Cultural barriers Lack of senior-level sponsorship In the financial service industry, where data integrity has been a concern for many years, it has been reported in 2008 less than 10 percent of organizations will succeed at their first attempts at data governance. This statistic may prove very informative for our industry as we embark on addressing data integrity assurance within our organisations!! 14

Data Governance Application The core of data governance is creating a framework to ensure that data generated is: Recorded Processed Retained Used To ensure data, throughout the data lifecycle, is: complete consistent accurate 15

Food for thought Manufacturers and analytical laboratories should be aware that reverting from automated / computerised to manual / paperbased systems will not in itself remove the need for data integrity controls. This may also constitute a failure to comply with Article 23 of Directive 2001/83/EC, which requires an authorisation holder to take account of scientific and technical progress and enable the medicinal product to be manufactured and checked by means of generally accepted scientific methods. Source: MHRA GMP Data Integrity Definitions and Guidance for Industry March 2015 16

The Data Governance Plan 17

Elements to be considered An overarching data governance system, should include : Relevant policies, standards Effort and resource applied should be commensurate with criticality in terms of impact to product quality attributes Staff training - general & role specific e.g. audit team Technical controls (e.g. computer system access) Consideration should be given to the organisational controls (e.g. procedures) 18

Practical Elements to be considered Systems should be designed in a way that encourages compliance e.g. : Access to clocks for recording timed events Accessibility of batch records at locations where activities take place so that ad hoc data recording and later transcription to official records is not necessary Control over blank paper templates for data recording User access rights which prevent (or audit trail) data amendments Automated data capture or printers attached to equipment such as balances Proximity of printers to relevant activities Access to sampling points (e.g. for water systems) Access to raw data for staff performing data checking activities. 19

Data Governance Plan The Governance Plan should consider the following two elements: o Prevention better than cure!!! o Detection safe guarding the data!!! Prevention 1 QMS modernisation CSV Data review policy Standards Vendors (metrics/controls) QTAs and templates Detection 1 Auditing Identifying risk factors Data review process Whistleblower 1 Not exhaustive lists 20

Data Integrity Governance Plan Require a phased approach to role out o Consider a PDCA model 21

Data Integrity Governance Plan- Phase 1 o Define a governance structure Governance at senior level, roll out a grass roots Appoint a Data Integrity Compliance Officer not owner!!! o Gain buy in from SLT & senior stakeholders o Communications plan o Education up and down the organisation o Market the project to instil the appropriate culture and bring awareness o Develop Metrics for tracking (project and DI) o Develop a Tool Kit Glossary and definitions (common language) Policies Standards Procedures Whistle blowers charter and structures Templates Gap Assessments, URS, SLAs, Validation, QTA, Audit etc. 22

PQS updates to support Data Integrity governance Metrics expecting the Bow Wave. Driving the right behaviours Data integrity statement Quality Manual update Development and amendment of standards Development and amendment of policies Development and amendment of procedures Development and amendment of templates and forms Cultural and behavioural owned by all championed by quality Training 23

Data Integrity and the QRM process Data Integrity Governance Site Risk Register Site Control Strategy Senior Management Quality Data Integrity Compliance Office SME SME SME SME SME SME SME Gap Assessments Required effort commensurate with risk Key Gaps Key Gaps Key Gaps Key Gaps Key Gaps Key Gaps Key Gaps Close Gaps and identify residual risks Close Gaps and identify residual risks Close Gaps and identify residual risks Close Gaps and identify residual risks Close Gaps and identify residual risks Close Gaps and identify residual risks Close Gaps and identify residual risks Data Integrity Risk Register & Control Strategy 24

Data Integrity Governance Plan- Phase 2 o Roll out the plan line in the sand o Mandated to each of the functional groups SMEs for actioning the activities o Complete a Gap Assessment of current state against the ideal Horizontal Cut Qualitative assessment Identify low, medium and high risk areas Deep Dive for the Medium, and High Risk areas commensurate with risk in the form of formal risk assessment Data lifecycle and business processing mapping 25

Data Integrity Governance Plan- Phase 2 Deviations Detailed data lifecycle and business processing mapping SOP Risk Assessment CAPA Identify High Medium Low risk Identification of risks for tracking role up residual risk into quality risk register for organisation Identify controls commensurate with risk 26

Data Integrity Governance Plan- Phase 3 & 4 Check Phase 3 o Governance team provide tracking and oversight during do phase tracking against project roll out o Important to understand that in the initial phase metrics may appear to look worse as issues are detected through the gap assessment and QRM activities Communication of this potential Bow Wave effect is important o Quick wins actions o Long term actions Act Phase 4 Sustain o Incorporate DI metrics into the Quality Management Review process and track o Incorporate DI into the self inspection & vendor qualification and oversight programs 27

Summary 28

Summary Overview of Data Integrity Applies to all data sources Patient Safety and Product Quality Assurance of Data Paper based, electronic or hybrid the same rules apply (ALCOA) Assuring appropriate data life cycle management Identifying and controlling internal and external factors Data Governance The core of data governance is creating a framework to ensure that data generated is recorded, processed, retained & used to ensure complete, consistent & accurate throughout the life cycle Cultural barriers and lack of senior-level sponsorship may be potential obstacles Reverting from automated / computerised to manual / paper-based systems will not in itself remove the need for data integrity controls The Data Governance Plan Should consider prevention and detection Relevant policies, standards, staff training, consideration should be given to the organisational controls, technical controls Effort and resource applied should be commensurate with criticality in terms of impact to product quality attributes Governance at a Management Level and roll out at a grass roots Things may appear worse before they get better metrics PQS, QRM and QMR 29

Questions? 30

Contact A Suite 2, Stafford House, Strand Road, Portmarnock, Co. Dublin, Ireland P +353 (0)1 846 47 42 E info@mcgeepharma.com F +353 (0)1 846 4898 W www.mcgeepharma.com 31